MedPath
NMPA Approval

Carbocysteine Oral Solution

国药准字H20247266

November 4, 2024

国药准字H20233839

Drug Information

羧甲司坦口服溶液

口服溶液剂

10ml∶0.2g

化学药品

November 4, 2024

Company Information

Applicant Company

东莞市石龙镇西湖工业区信息产业园

Manufacturing Company

广东省东莞市石龙镇西湖工业区信息产业园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

羧甲司坦口服溶液 - NMPA 批准文号 | MedPath